Escobar E, Gómez-Valenzuela F, Peñafiel C, Chimenos-Küstner E, Pérez-Tomás R. Aberrant immunoexpression of p53 tumour-suppressor and Bcl-2 family proteins (Bcl-2 and Bax) in ameloblastomas and odontogenic keratocysts. J Clin Exp Dent. 2023;15(2):e125-34.

doi:10.4317/jced.59769

__________

References

1. Elmore S. Apoptosis: a review of programmed cell death. Toxicologic Pathology. 2007;35:495-516. https://doi.org/10.1080/01926230701320337 PMid:17562483

2. Vaseva A V., Moll UM. The mitochondrial p53 pathway. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 2009;1787:414-20. https://doi.org/10.1016/j.bbabio.2008.10.005 PMid:19007744

3. Hemann MT, Lowe SW. The p53-Bcl-2 connection. Cell Death Differ. 2006;13:1256-1259. https://doi.org/10.1038/sj.cdd.4401962 PMid:16710363

4. Amaral JD, Xavier JM, Steer CJ, Rodrigues CM. The role of p53 in apoptosis. Discovery medicine. 2010;9:145-52.

5. Chaudhary Z, Sangwan V, Pal US, Sharma P. Unicystic ameloblastoma: A diagnostic dilemma. Case Reports Natl J Maxillofac Surg. 2011;2:89-92. https://doi.org/10.4103/0975-5950.85863 PMid:22442619

6. Vered M, Wright JM. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Odontogenic and Maxillofacial Bone Tumours. Head and neck pathology. 2022;16:63-75. https://doi.org/10.1007/s12105-021-01404-7 PMid:35312978

7. Kalogirou EM, Thermos G, Zogopoulos V, Foutadakis S, Michalopoulos I, Agelopoulos M, et al. The immunohistochemical profile of basal cell nevus syndrome-associated and sporadic odontogenic keratocysts: a systematic review and meta-analysis. Clinical oral investigations. 2021;25:3351-67. https://doi.org/10.1007/s00784-021-03877-w PMid:33730212

8. Smith RA, Tang J, Tudur-Smith C, Neoptolemos JP, Ghaneh P. Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer. British journal of cancer. 2011;104:1440-51. https://doi.org/10.1038/bjc.2011.110 PMid:21448172

9. Bree AF, Shah MR. Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS). American journal of medical genetics Part A. 2011;155A:2091-7. https://doi.org/10.1002/ajmg.a.34128 PMid:21834049

10. Clark P, Marker P, Bastian HL, Krogdahl A. Expression of p53, Ki-67, and EGFR in odontogenic keratocysts before and after decompression. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 2006;35:568-72. https://doi.org/10.1111/j.1600-0714.2006.00468.x PMid:16968238

11. Knudson CM, Johnson GM, Lin Y, Korsmeyer SJ. Bax accelerates tumorigenesis in p53-deficient mice. Cancer research. 2001;61:659-65. PMid:11212265

12. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nature Reviews Cancer. 2002;2:594-604. https://doi.org/10.1038/nrc864 PMid:12154352

13. Yemelyanova A, Vang R, Kshirsagar M, Lu D, Marks MA, Shih IM, et al. Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc. 2011;24:1248-53. https://doi.org/10.1038/modpathol.2011.85 PMid:21552211

14. García-Iglesias MJ, Cuevas-Higuera JL, Bastida-Sáenz A, de Garnica-García MG, Polledo L, Perero P, et al. Immunohistochemical detection of p53 and pp53 Ser(392) in canine hemangiomas and hemangiosarcomas located in the skin. BMC veterinary research. 2020;16:239. https://doi.org/10.1186/s12917-020-02457-6 PMid:32660487

15. Singh A, Jain A, Shetty DC, Rathore AS, Juneja S. Immunohistochemical expression of p53 and murine double minute 2 protein in odontogenic keratocyst versus variants of ameloblastoma. Journal of cancer research and therapeutics. 2020;16:521-9. https://doi.org/10.4103/jcrt.JCRT_659_18 PMid:32719261

16. Sharifi-Sistani N, Zartab H, Babakoohi S, Saghravanian N, Jamshidi S, Esmaili H, et al. Immunohistochemical comparison of the expression of p53 and MDM2 proteins in ameloblastomas and keratocystic odontogenic tumors. The Journal of craniofacial surgery. 2011;22:1652-6. https://doi.org/10.1097/SCS.0b013e31823188e9 PMid:21959406

17. Tenório JR, Santana T, Queiroz SIML, de Oliveira DHIP, Queiroz LMG. Apoptosis and cell cycle aberrations in epithelial odontogenic lesions: An evidence by the expression of p53, Bcl-2 and Bax. Medicina oral, patologia oral y cirugia bucal. 2018;23:e120-5. https://doi.org/10.4317/medoral.22019 PMid:29476674

18. Shetty DC, Urs AB, Godhi S, Gupta S. Classifying odontogenic keratocysts as benign cystic neoplasms: a molecular insight into its aggressiveness. Journal of Maxillofacial and Oral Surgery. 2010;9:30-4. https://doi.org/10.1007/s12663-010-0010-2 PMid:23139563

19. Singh T, Chandu A, Clement J, Angel C. Immunohistochemistry of Five Molecular Markers for Typing and Management of Ameloblastomas: A Retrospective Analysis of 40 Cases. Journal of maxillofacial and oral surgery. 2017;16:65-70. https://doi.org/10.1007/s12663-016-0923-5 PMid:28286387

20. Lo Muzio L, Staibano S, Pannone G, Bucci P, Nocini PF, Bucci E, et al. Expression of cell cycle and apoptosis-related proteins in sporadic odontogenic keratocysts and odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome. Journal of dental research. 1999;78:1345-53. https://doi.org/10.1177/00220345990780070901 PMid:10403462

21. Doll C, Dauter K, Jöhrens K, Hartwig S, Voss JO, Klein M, et al. Clinical characteristics and immunohistochemical analysis of p53, Ki-67 and cyclin D1 in 80 odontogenic keratocysts. Journal of stomatology, oral and maxillofacial surgery. 2018;119:359-64. https://doi.org/10.1016/j.jormas.2018.03.002 PMid:29530737

22. Slusarenko da Silva Y, Stoelinga PJW, Grillo R, da Graça Naclério-Homem M. Cyst or Tumor? A systematic review and meta-analysis on the expression of p53 marker in Odontogenic Keratocysts. Journal of cranio-maxillo-facial surgery: official publication of the European Association for Cranio-Maxillo-Facial Surgery. 2021;49:1101-6. https://doi.org/10.1016/j.jcms.2021.09.015 PMid:34620539

23. Soluk Tekkeşin M, Mutlu S, Olgaç V. Expressions of bax, bcl-2 and Ki-67 in odontogenic keratocysts (Keratocystic odontogenic tumor) in comparison with ameloblastomas and radicular cysts. Turk Patoloji Dergisi/Turkish Journal of Pathology. 2012;28:49-55. https://doi.org/10.5146/tjpath.2012.01097 PMid:22207432

24. González-González R, Molina-Frechero N, Damian-Matsumura P, Salazar-Rodriguez S, Bologna-Molina R. Immunohistochemical expression of Survivin and its relationship with cell apoptosis and proliferation in ameloblastomas. Disease markers. 2015;2015:301781. https://doi.org/10.1155/2015/301781 PMid:25866434

25. Rangiani A, Motahhary P. Evaluation of bax and bcl-2 expression in odontogenic keratocysts and orthokeratinized odontogenic cysts: A comparison of two cysts. Oral Oncology. 2009;45:e41-4. https://doi.org/10.1016/j.oraloncology.2008.12.007 PMid:19362040

26. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993;74:609-19. https://doi.org/10.1016/0092-8674(93)90509-O PMid:8358790

27. Vaskivuo TE, Stenbäck F, Tapanainen JS. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma. Cancer. 2002;95:1463-71. https://doi.org/10.1002/cncr.10876 PMid:12237915

28. Zhang M, Zhang P, Zhang C, Sun J, Wang L, Li J, et al. Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma. Journal of oral pathology & medicine: official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 2009;38:307-13. https://doi.org/10.1111/j.1600-0714.2008.00689.x PMid:18710422